CRISIL surges on reporting 39% rise in Q1 consolidated net profit

CRISIL is currently trading at Rs 1251.00, up by 37.90 points or 3.12% from its previous closing of Rs 1213.10 on the BSE. The scrip opened at Rs. 1220.00 and has touched a high and low of Rs. 1276.00 and Rs. 1220.00 respectively. So far 1990 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1276.00 on 17-Apr-2013 and a 52 week low of Rs. 889.05 on 23-Apr-2013. Last one week high and low of the scrip stood at Rs. 1245.00 and Rs. 1201.90 respectively. The current market cap of the company is Rs. 8838.68 crore. The promoters holding in the company stood at 67.70 % while Institutions and Non-Institutions held 18.52 % and 13.78 % respectively. CRISIL has reported results for first quarter ended March 31, 2014 The company has posted a rise of 11.75% in its net profit at Rs 50.96 crore for the quarter ended March 31, 2014 as compared to Rs 45.60 crore for the same quarter in the previous year. Total income of the company has increased by 16.61% at Rs 224.62 crore for quarter under review as compared to Rs 192.61 crore for the quarter ended March 31, 2013. On the consolidated basis, the company has reported 38.61% rise in its net profit at Rs 68.71 crore for the quarter as compared to Rs 49.57 crore for the same quarter in the previous year. Total income of the company has increased by 20.87% at Rs 312.12 crore for quarter under review as compared to Rs 258.21 crore for the quarter ended March 31, 2013.

GlaxoSmithKline Pharma declines on reporting 43% fall in Q1 net profit

Glaxosmithkline Pharmaceuticals is currently trading at Rs 2475.00, down by 33.10 points or 1.32% from its previous closing of Rs 2508.10 on the BSE. The scrip opened at Rs. 2510.00 and has touched a high and low of Rs 2547.00 and Rs 2455.25 respectively. So far 2521 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 3054.40 on 03-Mar-2014 and a 52 week low of Rs. 2155.00 on 29-Apr-2013. Last one week high and low of the scrip stood at Rs. 2561.00 and Rs. 2485.00 respectively. The current market cap of the company is Rs. 21218.53 crore. The promoters holding in the company stood at 75.00 % while Institutions and Non-Institutions held 11.46 % and 13.54 % respectively. GlaxoSmithKline Pharmaceuticals has reported results for first quarter ended March 31, 2014 The company has posted 42.88% fall in net profit at Rs 96.54 crore for the quarter ended March 31, 2014 as compared to Rs 169.00 crore for the same quarter in the previous year. Total income of the company has decreased by 8.28% at Rs 654.73 crore for quarter under review as compared to Rs 713.84 crore for the quarter ended March 31, 2013. GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.

FIIs reduce stake in Indraprastha Gas to 15.52% during March quarter

Foreign Institutional Investors (FIIs) have reduced their shareholding in Indraprastha Gas to 15.52% at the end of March 2014 quarter from 19.58% as on December 31, 2013. On the other hand, domestic institutional investors’ (DIIs) shareholding went up to 23.12% during Q4FY14from 18.74% as on December 31, 2013. Under DIIs, Insurance companies held maximum stake of 8.87%, followed by mutual funds / UTI (8.32% stake), Central Government / State Government (5% stake) and financial institutions / banks (0.93% stake). Meanwhile, promoter and promoter group shareholding was unchanged at 45% at the end of March 2014 quarter. Indraprastha Gas, incorporated in 1998, is engaged in distribution of Compressed Natural Gas (CNG) and Piped Natural Gas (PNG) in Delhi. In 1999 the company took over Delhi City Gas Distribution Project from GAIL (India). IGL laid the network for the distribution of natural gas in the National Capital of Delhi to consumers in the domestic, transport, and commercial sectors.

CRISIL reports 39% rise in Q1 consolidated net profit

CRISIL has reported results for first quarter ended March 31, 2014 The company has posted a rise of 11.75% in its net profit at Rs 50.96 crore for the quarter ended March 31, 2014 as compared to Rs 45.60 crore for the same quarter in the previous year. Total income of the company has increased by 16.61% at Rs 224.62 crore for quarter under review as compared to Rs 192.61 crore for the quarter ended March 31, 2013. On the consolidated basis, the company has reported 38.61% rise in its net profit at Rs 68.71 crore for the quarter as compared to Rs 49.57 crore for the same quarter in the previous year. Total income of the company has increased by 20.87% at Rs 312.12 crore for quarter under review as compared to Rs 258.21 crore for the quarter ended March 31, 2013.

Mahindra & Mahindra surges on BSE

Mahindra & Mahindra is currently trading at Rs. 995.00, up by 19.65 points or 2.01 % from its previous closing of Rs. 975.35 on the BSE. The scrip opened at Rs. 978.00 and has touched a high and low of Rs. 997.70 and Rs. 978.00 respectively. So far 22745 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1054.00 on 18-Mar-2014 and a 52 week low of Rs. 741.50 on 28-Aug-2013. Last one week high and low of the scrip stood at Rs. 1026.00 and Rs. 964.70 respectively. The current market cap of the company is Rs. 61142.72 crore. The promoters holding in the company stood at 25.29 % while Institutions and Non-Institutions held 52.80 % and 16.92 % respectively. Credit rating agency, CARE has reaffirmed ‘AA+’ rating to Mahindra & Mahindra’s long term bank facilities worth Rs 178.28 crore and ‘A1+’ rating to company’s Short term Bank Facilities worth Rs 71.72 crore. The company has received the said ratings on the back of its experience promoters and management and dominant position in the Utility Vehicle (UV) and Farm equipment (FE) segments, its established brand image, diversified product portfolio, strong dealer and after-sales service network and its global presence. Mahindra & Mahindra (M&M) is the flagship company of the Mahindra Group, a multinational conglomerate based in Mumbai, India. Amongst the various business interests of its parent group, the company is mainly involved in the automobile manufacturing. It is one of the leading auto companies of India.

Religare Invesco MF introduces Fixed Maturity Plan - Series 23 - Plan K (775 Days)

Religare Invesco Mutual Fund has launched the New Fund Offer (NFO) of Religare Invesco Fixed Maturity Plan - Series 23 - Plan K (775 Days), a close ended income scheme. The NFO opens for subscription on Apr 17, 2014, and closes on Apr 23, 2014. No entry load or exit load will be applicable for the scheme. The minimum subscription amount is Rs 5000 and in multiples of Rs 10 thereafter. The scheme’s performance will be benchmarked against CRISIL Short Term Bond Fund Index and its fund manager is Nitish Sikand. The investment objective of the scheme is to generate income by investing in a portfolio of debt and money market instruments maturing on or before the date of maturity of the scheme.

GlaxoSmithKline Pharma reports around six fold jump in Q1 net profit

GlaxoSmithKline Pharmaceuticals has reported results for first quarter ended March 31, 2014 The company has posted a jump of around six fold in its net profit at Rs 96.54 crore for the quarter ended March 31, 2014 as compared to Rs 16.90 crore for the same quarter in the previous year. However, total income of the company has decreased by 8.28% at Rs 654.73 crore for quarter under review as compared to Rs 713.84 crore for the quarter ended March 31, 2013. GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.

Reliance MF introduces Fixed Horizon Fund XXVI- Series 15

Reliance Mutual Fund has launched the New Fund Offer (NFO) of Reliance Fixed Horizon Fund XXVI- Series 15, a close ended income scheme. The NFO opens for subscription on Apr 17, 2014, and closes on Apr 22, 2014. No entry load or exit load will be applicable for the scheme. The minimum subscription amount is Rs 5000 and in multiples of Re 1 thereafter.

The scheme’s performance will be benchmarked against CRISIL Short Term Bond Fund Index and its fund manager is Amit Tripathi.

The investment objective of the scheme is to generate returns and growth of capital by investing in a diversified portfolio of the following securities maturing on or before the date of maturity of the scheme with the objective of limiting interest rate volatility - Central and State Government securities and other fixed income/ debt securities.

Bharti Airtel trades higher on the bourses

Bharti Airtel is currently trading at Rs. 324.80, up by 1.50 points or 0.46% from its previous closing of Rs. 323.30 on the BSE. The scrip opened at Rs. 324.55 and has touched a high and low of Rs. 326.75 and Rs. 321.30 respectively. So far 88071 shares were traded on the counter. The BSE group 'A ' stock of face value Rs. 5 has touched a 52 week high of Rs. 373.50 on 01-Nov-2013 and a 52 week low of Rs. 274.50 on 11-Jun-2013. Last one week high and low of the scrip stood at Rs. 330.00 and Rs. 316.50 respectively. The current market cap of the company is Rs. 130075.40 crore. The promoters holding in the company stood at 65.32% while Institutions and Non-Institutions held 24.17% and 10.51% respectively. Bharti Airtel has unveiled its ‘Night Store’, a first of its kind store that will enable customers to buy value for money offers on their prepaid mobile for internet usage and local calling at night, 12 midnight - 6am. Under these services, the company’s pre-paid customers can make unlimited calls to local Airtel numbers for Rs 7, unlimited 2G mobile internet for Rs 8 and combination of both these services for Rs 15. The company is also offering 500 MB of 3G service for Rs 29 and 1GB of 3G for Rs 49 during night in service areas where it has 3G spectrum. It has also made access to Facebook free during night hours which users can activate by dialing 129. Bharti Airtel is a leading integrated telecommunications company with operations in 20 countries across Asia and Africa. The company ranks amongst the top 5 mobile service providers globally in terms of subscribers.

ICICI Bank surges as FIIs hike stake during March quarter

ICICI Bank is currently trading at Rs. 1249.00, up by 26.70 points or 2.18% from its previous closing of Rs. 1222.30 on the BSE. The scrip opened at Rs. 1236.25 and has touched a high and low of Rs. 1259.90 and Rs. 1227.20 respectively. So far 166876 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1272.90 on 27-Mar-2014 and a 52 week low of Rs. 758.80 on 28-Aug-2013. Last one week high and low of the scrip stood at Rs. 1268.95 and Rs. 1214.40 respectively. The current market cap of the company is Rs. 145095.98 crore. The Institutions and Non-Institutions held 63.07% and 7.77% stake in the bank, respectively. Foreign institutional investors (FIIs) are continuing their buying spree in ICICI Bank, with their holdings in the country’s leading private sector lender touching a six-year high of 39.85% in the January-March period of 2014. FIIs bought an additional 1.46 percentage points stake in the bank during Q4FY14. FIIs held 38.39% stake in the bank during the October-December quarter. Moreover, the current FII holding of 39.85% in the country’s second largest private sector bank in terms of market capitalization is the highest in six years. The level stood at 40.30% during the quarter ended March 31, 2008. FIIs held as much as 46.4% stake in ICICI Bank during the December 2004 quarter. This was the second quarterly increase in FII holding in ICICI Bank. In the past two quarters, FIIs hiked their stake in ICICI Bank by 2.31 percentage points from 37.54% at the end of September 30, 2013 quarter. Meanwhile, Life Insurance Corporation of India has reduced its holdings in ICICI Bank to 8.74% in the March quarter from 9.7% in the December quarter. The insurance giant held 10.46% stake in the bank at the end of September quarter.